Skip to main content
Premium Trial:

Request an Annual Quote

Promega, Leica to Develop Fluorescent Proteins for Live-Cell Imaging

NEW YORK (GenomeWeb News) – Promega said today that it has signed an agreement with Leica Microsystems to develop fluorescent labels for proteins so that they can be visualized in live cells using a Leica super-resolution microscope.
Promega said it will develop fluorescent ligands for its HaloTag fusion proteins, which will be visualized within live cells using Leica’s TCS stimulated emission depletion, or STED, microscope. 
Current fluorescent imaging methods, such as green fluorescent protein, are generally not optimal for use with STED technology, the company said, because they “are prone to photobleaching and lack appropriate spectral properties,” while other protein-labeling methods, such as fluorescent antibodies, are only applicable to fixed cells.
Promega said that the agreement with Leica will enable the imaging of proteins within live cells below the 100-nanometer range.
It added that it has been working with the imaging company since 2006 to develop novel ways to label proteins within cells.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.